This inventor holds 3 USPTO granted patents. Top assignee: Shenyang Pharmaceutical University. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2017
Title: Linxiang Zhao: Innovator in Medicinal Chemistry
Introduction
Linxiang Zhao is a prominent inventor based in Shenyang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for cancer treatment. With a total of three patents to his name, Zhao's work is paving the way for advancements in pharmaceutical applications.
Latest Patents
Zhao's latest patents include innovative compounds that hold promise for cancer therapy. One of his notable inventions is the "Nitrogen-containing heterocyclic ring substituted dihydroartemisinin derivatives and use thereof." This invention focuses on derivatives that can be formulated into various clinically acceptable forms, such as tablets and injections, for the treatment and prevention of cancers. Another significant patent is the "2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof." This invention details derivatives that serve as active components in medicines aimed at treating various types of cancer, including breast, lung, and prostate cancers.
Career Highlights
Linxiang Zhao is affiliated with Shenyang Pharmaceutical University, where he conducts research and develops his innovative ideas. His work is characterized by a strong focus on creating effective therapeutic agents that can significantly impact cancer treatment.
Collaborations
Zhao collaborates with esteemed colleagues in his field, including Dan Liu and Yongkui Jing. These partnerships enhance the research and development process, allowing for a more comprehensive approach to medicinal innovation.
Conclusion
Linxiang Zhao's contributions to medicinal chemistry exemplify the importance of innovation in the fight against cancer. His patents reflect a commitment to developing effective treatments that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile